MENU
+Compare
ORGO
Stock ticker: NASDAQ
AS OF
Jun 26, 10:45 AM (EDT)
Price
$3.57
Change
+$0.03 (+0.85%)
Capitalization
374.78M

ORGO Organogenesis Holdings Forecast, Technical & Fundamental Analysis

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets... Show more

ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ORGO with price predictions
Jun 25, 2025

ORGO's Indicator enters downward trend

The Aroon Indicator for ORGO entered a downward trend on June 12, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 216 similar instances where the Aroon Indicator formed such a pattern. In of the 216 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where ORGO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ORGO broke above its upper Bollinger Band on June 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ORGO's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 06, 2025. You may want to consider a long position or call options on ORGO as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ORGO just turned positive on June 05, 2025. Looking at past instances where ORGO's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ORGO advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.331) is normal, around the industry mean (62.463). P/E Ratio (70.250) is within average values for comparable stocks, (89.614). ORGO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.861) is also within normal values, averaging (19.198).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ORGO is expected to report earnings to fall 63.24% to -6 cents per share on August 06

Organogenesis Holdings ORGO Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.11
Q2'24
Missed
by $0.14
The last earnings report on May 08 showed earnings per share of -17 cents, missing the estimate of -3 cents. With 29.58K shares outstanding, the current market capitalization sits at 374.78M.
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
85 Dan Road
Phone
+1 781 575-0775
Employees
862
Web
https://www.organogenesis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGICX72.18N/A
N/A
Janus Henderson Growth And Income C
DQEIX12.95N/A
N/A
BNY Mellon Global Equity Income - I
BGEEX17.94N/A
N/A
BlackRock GA Dynamic Eq K
EEOFX13.70-0.09
-0.65%
Pear Tree Essex Environmental Opps Odnry
REBYX24.16-0.29
-1.19%
Russell Inv US Small Cap Equity Y

ORGO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
+2.31%
ANIP - ORGO
48%
Loosely correlated
-1.60%
PRGO - ORGO
46%
Loosely correlated
-0.49%
AMRX - ORGO
31%
Poorly correlated
-0.98%
ACET - ORGO
29%
Poorly correlated
+0.58%
AMPH - ORGO
27%
Poorly correlated
-4.60%
More